| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Otitis Media | 5 | 2019 | 106 | 1.91 | Why? |
| Community-Acquired Infections | 7 | 2019 | 2328 | 1.67 | Why? |
| Pneumococcal Vaccines | 4 | 2017 | 571 | 1.36 | Why? |
| Pertussis Vaccine | 2 | 2018 | 89 | 1.33 | Why? |
| Whooping Cough | 2 | 2018 | 201 | 1.18 | Why? |
| Influenza Vaccines | 6 | 2018 | 2941 | 1.08 | Why? |
| Anti-Bacterial Agents | 12 | 2019 | 10083 | 0.94 | Why? |
| Dysbiosis | 2 | 2017 | 685 | 0.89 | Why? |
| Pneumonia | 6 | 2019 | 5652 | 0.85 | Why? |
| Parvoviridae Infections | 2 | 2015 | 222 | 0.82 | Why? |
| Respiratory Tract Infections | 10 | 2018 | 6817 | 0.82 | Why? |
| Neurotoxicity Syndromes | 2 | 2018 | 124 | 0.81 | Why? |
| Influenza, Human | 8 | 2018 | 10779 | 0.74 | Why? |
| Aluminum | 1 | 2018 | 71 | 0.71 | Why? |
| Bronchopulmonary Dysplasia | 1 | 2018 | 53 | 0.70 | Why? |
| Cushing Syndrome | 1 | 2018 | 76 | 0.69 | Why? |
| Schools | 4 | 2021 | 4187 | 0.69 | Why? |
| Vaccines, Attenuated | 3 | 2017 | 952 | 0.68 | Why? |
| Celiac Disease | 3 | 2018 | 471 | 0.68 | Why? |
| Bacterial Infections | 6 | 2018 | 2229 | 0.65 | Why? |
| Mumps | 1 | 2018 | 110 | 0.64 | Why? |
| Child Behavior | 1 | 2020 | 266 | 0.64 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2018 | 115 | 0.63 | Why? |
| Nasal Lavage | 1 | 2017 | 91 | 0.63 | Why? |
| Drugs, Investigational | 1 | 2019 | 198 | 0.63 | Why? |
| Virus Diseases | 4 | 2017 | 3779 | 0.63 | Why? |
| Herpes Zoster Vaccine | 1 | 2017 | 112 | 0.61 | Why? |
| Irritable Bowel Syndrome | 1 | 2017 | 175 | 0.58 | Why? |
| Human bocavirus | 1 | 2015 | 142 | 0.57 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2018 | 282 | 0.57 | Why? |
| Calcitonin | 2 | 2018 | 201 | 0.56 | Why? |
| Vaccines | 3 | 2018 | 3692 | 0.56 | Why? |
| Child Welfare | 1 | 2020 | 405 | 0.55 | Why? |
| Child | 38 | 2021 | 70012 | 0.55 | Why? |
| Rotavirus | 1 | 2017 | 329 | 0.54 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.53 | Why? |
| Intensive Care Units, Pediatric | 1 | 2021 | 1098 | 0.53 | Why? |
| Pneumonia, Bacterial | 2 | 2018 | 843 | 0.53 | Why? |
| Pneumonia, Pneumococcal | 1 | 2016 | 251 | 0.52 | Why? |
| Hashimoto Disease | 3 | 2018 | 74 | 0.51 | Why? |
| Probiotics | 2 | 2018 | 694 | 0.51 | Why? |
| Vaccines, Inactivated | 2 | 2018 | 1562 | 0.50 | Why? |
| Surgical Wound Infection | 1 | 2018 | 501 | 0.49 | Why? |
| Mycoplasma Infections | 1 | 2012 | 65 | 0.48 | Why? |
| Respiratory Syncytial Virus Infections | 2 | 2015 | 1234 | 0.48 | Why? |
| Respiratory Tract Diseases | 2 | 2017 | 1061 | 0.46 | Why? |
| Herpes Zoster | 1 | 2017 | 331 | 0.46 | Why? |
| Bacteria | 3 | 2017 | 1897 | 0.46 | Why? |
| Picornaviridae Infections | 2 | 2014 | 544 | 0.45 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.45 | Why? |
| Vaccination Coverage | 2 | 2018 | 1249 | 0.45 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.45 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.45 | Why? |
| Respiratory Syncytial Viruses | 1 | 2015 | 612 | 0.44 | Why? |
| Pneumococcal Infections | 1 | 2017 | 562 | 0.43 | Why? |
| Mycoplasma pneumoniae | 1 | 2012 | 233 | 0.43 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2020 | 1138 | 0.43 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.43 | Why? |
| Child Health | 1 | 2020 | 940 | 0.42 | Why? |
| Infant | 23 | 2019 | 30274 | 0.42 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.39 | Why? |
| Child, Preschool | 22 | 2019 | 36283 | 0.39 | Why? |
| Macrolides | 1 | 2012 | 369 | 0.38 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.37 | Why? |
| Gastroenteritis | 2 | 2017 | 489 | 0.37 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.37 | Why? |
| Vaccination | 7 | 2018 | 19050 | 0.35 | Why? |
| Humans | 85 | 2021 | 930598 | 0.35 | Why? |
| Gastrointestinal Microbiome | 2 | 2018 | 1961 | 0.34 | Why? |
| Protein Precursors | 1 | 2011 | 425 | 0.34 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2015 | 1439 | 0.33 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.33 | Why? |
| Orthomyxoviridae | 1 | 2015 | 1168 | 0.32 | Why? |
| Enterovirus D, Human | 2 | 2018 | 96 | 0.32 | Why? |
| Health Education | 1 | 2018 | 1539 | 0.32 | Why? |
| Diabetes Mellitus, Type 1 | 2 | 2017 | 1969 | 0.31 | Why? |
| Diet, Gluten-Free | 2 | 2017 | 185 | 0.30 | Why? |
| Respiratory Sounds | 1 | 2008 | 294 | 0.29 | Why? |
| Respiratory Syncytial Virus, Human | 2 | 2012 | 846 | 0.29 | Why? |
| Guillain-Barre Syndrome | 1 | 2018 | 1495 | 0.29 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.28 | Why? |
| Streptococcal Infections | 2 | 2017 | 255 | 0.28 | Why? |
| Antigens, Bacterial | 2 | 2018 | 330 | 0.28 | Why? |
| Immunization Programs | 1 | 2017 | 2006 | 0.28 | Why? |
| Fluoroquinolones | 2 | 2019 | 235 | 0.28 | Why? |
| Ultrasonography | 5 | 2018 | 4409 | 0.28 | Why? |
| Drug Resistance, Bacterial | 2 | 2018 | 1414 | 0.27 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.27 | Why? |
| Cough | 1 | 2017 | 4891 | 0.26 | Why? |
| Masks | 3 | 2020 | 8528 | 0.25 | Why? |
| Fever | 2 | 2018 | 7795 | 0.25 | Why? |
| Rhinovirus | 3 | 2014 | 979 | 0.25 | Why? |
| Enterovirus Infections | 2 | 2018 | 404 | 0.24 | Why? |
| Nasopharynx | 4 | 2018 | 10224 | 0.23 | Why? |
| Health Policy | 2 | 2020 | 6242 | 0.22 | Why? |
| Clinical Trials as Topic | 2 | 2017 | 7330 | 0.21 | Why? |
| Immunization Schedule | 2 | 2018 | 1305 | 0.21 | Why? |
| Neisseriaceae Infections | 1 | 2000 | 21 | 0.21 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.21 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.20 | Why? |
| Immunization, Secondary | 2 | 2018 | 1649 | 0.20 | Why? |
| Erythromycin | 1 | 2019 | 17 | 0.20 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.20 | Why? |
| Cefotaxime | 1 | 2019 | 31 | 0.20 | Why? |
| Coronavirus Infections | 11 | 2021 | 253789 | 0.20 | Why? |
| Vaccines, Conjugate | 2 | 2017 | 328 | 0.20 | Why? |
| Haemophilus Infections | 1 | 2000 | 69 | 0.20 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2019 | 72 | 0.20 | Why? |
| Adrenocortical Hyperfunction | 1 | 2018 | 2 | 0.20 | Why? |
| Vaccines, Acellular | 1 | 2018 | 12 | 0.19 | Why? |
| Phyllodes Tumor | 1 | 2018 | 5 | 0.19 | Why? |
| Molecular Diagnostic Techniques | 1 | 2015 | 4239 | 0.19 | Why? |
| Vulva | 1 | 2018 | 31 | 0.19 | Why? |
| Aminoglycosides | 1 | 2019 | 94 | 0.19 | Why? |
| Cephalosporins | 2 | 2000 | 250 | 0.19 | Why? |
| Microfilament Proteins | 1 | 2018 | 45 | 0.19 | Why? |
| Early Diagnosis | 3 | 2018 | 2443 | 0.19 | Why? |
| Munchausen Syndrome | 1 | 2018 | 7 | 0.19 | Why? |
| Discitis | 1 | 2018 | 23 | 0.18 | Why? |
| Coronavirus | 4 | 2021 | 18339 | 0.18 | Why? |
| Malformations of Cortical Development | 1 | 2017 | 10 | 0.18 | Why? |
| Neuroendocrine Cells | 1 | 2017 | 9 | 0.18 | Why? |
| Vulvar Diseases | 1 | 2018 | 38 | 0.18 | Why? |
| Viruses | 1 | 2012 | 2238 | 0.18 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.18 | Why? |
| Puberty, Precocious | 1 | 2018 | 33 | 0.18 | Why? |
| Esophageal Atresia | 1 | 2017 | 24 | 0.18 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.18 | Why? |
| Tubulin | 1 | 2017 | 67 | 0.18 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.18 | Why? |
| Psychology, Child | 1 | 2020 | 206 | 0.18 | Why? |
| Renal Colic | 1 | 2018 | 44 | 0.18 | Why? |
| Tympanic Membrane Perforation | 1 | 2017 | 5 | 0.17 | Why? |
| Spasms, Infantile | 1 | 2018 | 73 | 0.17 | Why? |
| Tracheoesophageal Fistula | 1 | 2017 | 32 | 0.17 | Why? |
| Addison Disease | 1 | 2017 | 24 | 0.17 | Why? |
| Bulimia Nervosa | 1 | 2017 | 25 | 0.17 | Why? |
| Bordetella pertussis | 1 | 2018 | 117 | 0.17 | Why? |
| Muscle Hypotonia | 1 | 2017 | 16 | 0.17 | Why? |
| Bacterial Vaccines | 1 | 2018 | 139 | 0.17 | Why? |
| Recurrence | 4 | 2019 | 3675 | 0.17 | Why? |
| Hyperplasia | 1 | 2017 | 204 | 0.17 | Why? |
| Binge-Eating Disorder | 1 | 2017 | 51 | 0.16 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 11367 | 0.16 | Why? |
| Product Surveillance, Postmarketing | 1 | 2019 | 189 | 0.16 | Why? |
| Tachypnea | 1 | 2017 | 197 | 0.16 | Why? |
| Acute Disease | 4 | 2019 | 6029 | 0.16 | Why? |
| Healthy Aging | 1 | 2018 | 147 | 0.16 | Why? |
| Osteomyelitis | 1 | 2018 | 131 | 0.16 | Why? |
| Paralysis | 1 | 2017 | 92 | 0.16 | Why? |
| Biofilms | 1 | 2019 | 304 | 0.16 | Why? |
| Diagnosis, Differential | 4 | 2018 | 7220 | 0.15 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
| Anorexia Nervosa | 1 | 2017 | 103 | 0.15 | Why? |
| Italy | 11 | 2021 | 38444 | 0.15 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.15 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.15 | Why? |
| Fatigue Syndrome, Chronic | 1 | 2018 | 160 | 0.15 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.15 | Why? |
| Myelitis | 1 | 2017 | 122 | 0.15 | Why? |
| Molecular Epidemiology | 2 | 2018 | 1638 | 0.14 | Why? |
| Enterobacteriaceae | 1 | 2019 | 395 | 0.14 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.14 | Why? |
| Communicable Disease Control | 4 | 2021 | 29620 | 0.14 | Why? |
| Peripheral Nervous System Diseases | 1 | 2017 | 193 | 0.14 | Why? |
| Administration, Oral | 2 | 2019 | 2340 | 0.14 | Why? |
| Rotavirus Vaccines | 1 | 2017 | 203 | 0.14 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
| Gastrointestinal Diseases | 1 | 2010 | 2580 | 0.14 | Why? |
| Lung | 3 | 2018 | 31049 | 0.14 | Why? |
| Parenting | 1 | 2020 | 486 | 0.14 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.13 | Why? |
| Infant, Newborn | 7 | 2018 | 23105 | 0.13 | Why? |
| Rhabdomyolysis | 1 | 2018 | 287 | 0.13 | Why? |
| Disease Outbreaks | 3 | 2018 | 27595 | 0.13 | Why? |
| Pericardial Effusion | 1 | 2017 | 312 | 0.13 | Why? |
| Rotavirus Infections | 1 | 2017 | 355 | 0.13 | Why? |
| Female | 23 | 2019 | 380317 | 0.12 | Why? |
| Population Surveillance | 1 | 2010 | 4967 | 0.12 | Why? |
| Preventive Health Services | 1 | 2018 | 501 | 0.12 | Why? |
| Nasal Cavity | 1 | 2018 | 909 | 0.12 | Why? |
| Pharyngitis | 1 | 2017 | 687 | 0.12 | Why? |
| Treatment Outcome | 8 | 2018 | 51732 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.12 | Why? |
| Ascorbic Acid | 1 | 2018 | 676 | 0.12 | Why? |
| Tetracyclines | 1 | 2012 | 82 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.12 | Why? |
| Calcitonin Gene-Related Peptide | 1 | 2011 | 52 | 0.11 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.11 | Why? |
| Anticonvulsants | 1 | 2017 | 634 | 0.11 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.11 | Why? |
| Influenza B virus | 1 | 2017 | 815 | 0.11 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.11 | Why? |
| Feeding and Eating Disorders | 1 | 2017 | 525 | 0.11 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.11 | Why? |
| Pharynx | 1 | 2018 | 1544 | 0.10 | Why? |
| Male | 24 | 2018 | 367725 | 0.10 | Why? |
| Phylogeny | 4 | 2018 | 13341 | 0.10 | Why? |
| Autism Spectrum Disorder | 1 | 2018 | 587 | 0.10 | Why? |
| Atypical Bacterial Forms | 1 | 2008 | 10 | 0.10 | Why? |
| Thorax | 1 | 2019 | 1873 | 0.10 | Why? |
| Prevalence | 6 | 2018 | 25773 | 0.10 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.09 | Why? |
| Bocavirus | 1 | 2008 | 74 | 0.09 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.09 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 1261 | 0.09 | Why? |
| Viral Load | 3 | 2015 | 15850 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.09 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.09 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.09 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Thyroid Function Tests | 2 | 2018 | 200 | 0.09 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.08 | Why? |
| Age Factors | 2 | 2019 | 21039 | 0.08 | Why? |
| Viremia | 1 | 2014 | 1020 | 0.08 | Why? |
| Communicable Diseases | 2 | 2018 | 2148 | 0.08 | Why? |
| Lung Diseases, Interstitial | 1 | 2017 | 1476 | 0.08 | Why? |
| Mass Vaccination | 1 | 2016 | 1101 | 0.08 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.08 | Why? |
| Thyroxine | 2 | 2018 | 250 | 0.08 | Why? |
| Radiography | 1 | 2014 | 1576 | 0.08 | Why? |
| Risk | 1 | 2018 | 5288 | 0.08 | Why? |
| Animals | 4 | 2019 | 78931 | 0.07 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.07 | Why? |
| Epilepsy | 1 | 2017 | 1401 | 0.07 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Patient Selection | 1 | 2019 | 4560 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Global Health | 2 | 2019 | 13911 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Pregnant Women | 1 | 2017 | 2535 | 0.07 | Why? |
| Cystic Fibrosis | 1 | 2014 | 1104 | 0.07 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.06 | Why? |
| Recombination, Genetic | 1 | 2010 | 1265 | 0.06 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.06 | Why? |
| Bronchiolitis | 1 | 2007 | 297 | 0.06 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.06 | Why? |
| Syndrome | 2 | 2018 | 1310 | 0.06 | Why? |
| Virulence | 1 | 2010 | 2172 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.05 | Why? |
| Radiography, Thoracic | 1 | 2017 | 5486 | 0.05 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.05 | Why? |
| Streptococcus | 1 | 2000 | 76 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Internet | 1 | 2018 | 6204 | 0.05 | Why? |
| Haemophilus influenzae | 1 | 2000 | 196 | 0.05 | Why? |
| Genetic Carrier Screening | 1 | 2018 | 18 | 0.05 | Why? |
| Bifidobacterium | 1 | 2018 | 52 | 0.05 | Why? |
| Iron-Binding Proteins | 1 | 2017 | 10 | 0.05 | Why? |
| Iodide Peroxidase | 1 | 2017 | 19 | 0.05 | Why? |
| Coronavirus OC43, Human | 1 | 2006 | 1157 | 0.05 | Why? |
| Secondary Prevention | 1 | 2003 | 762 | 0.04 | Why? |
| Coronavirus 229E, Human | 1 | 2006 | 1241 | 0.04 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.04 | Why? |
| Exanthema | 1 | 2008 | 1097 | 0.04 | Why? |
| Lactobacillus | 1 | 2018 | 92 | 0.04 | Why? |
| Mice | 1 | 2017 | 21357 | 0.04 | Why? |
| Bulgaria | 1 | 2017 | 117 | 0.04 | Why? |
| Gentamicins | 1 | 1977 | 76 | 0.04 | Why? |
| Magnetic Resonance Imaging | 3 | 2018 | 6551 | 0.04 | Why? |
| Immunocompromised Host | 1 | 2014 | 5150 | 0.04 | Why? |
| Exudates and Transudates | 1 | 2017 | 92 | 0.04 | Why? |
| Viral Vaccines | 1 | 2018 | 7560 | 0.04 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.04 | Why? |
| Lumbar Vertebrae | 1 | 2018 | 196 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2017 | 48226 | 0.04 | Why? |
| Thyrotropin | 1 | 2017 | 262 | 0.04 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.04 | Why? |
| Hypothyroidism | 1 | 2017 | 239 | 0.04 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Autoantigens | 1 | 2017 | 388 | 0.04 | Why? |
| Asthma | 1 | 2014 | 4383 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.04 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.04 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2015 | 22971 | 0.03 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Chemokines | 1 | 1999 | 1095 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 1977 | 534 | 0.03 | Why? |
| Coinfection | 1 | 2012 | 6820 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Electroencephalography | 1 | 2018 | 1242 | 0.03 | Why? |
| China | 1 | 2018 | 50654 | 0.03 | Why? |
| Socioeconomic Factors | 1 | 2008 | 8495 | 0.03 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Congresses as Topic | 1 | 2018 | 1347 | 0.02 | Why? |
| Cephradine | 1 | 1987 | 1 | 0.02 | Why? |
| Emergency Service, Hospital | 2 | 2018 | 14232 | 0.02 | Why? |
| Pediatrics | 2 | 2018 | 2969 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Practice Guidelines as Topic | 1 | 2011 | 15421 | 0.02 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Lymphocytes | 1 | 1999 | 3056 | 0.02 | Why? |
| Health Resources | 1 | 2018 | 2592 | 0.02 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.02 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Aging | 1 | 1999 | 3581 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Infant, Premature | 1 | 2007 | 883 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2007 | 3198 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Macrophage Inflammatory Proteins | 1 | 1999 | 14 | 0.01 | Why? |
| Chemokine CCL4 | 1 | 1999 | 71 | 0.01 | Why? |
| Chemokine CCL3 | 1 | 1999 | 103 | 0.01 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.01 | Why? |
| Base Sequence | 1 | 2007 | 3581 | 0.01 | Why? |
| Chemokine CCL5 | 1 | 1999 | 169 | 0.01 | Why? |
| Bacteriuria | 1 | 1977 | 31 | 0.01 | Why? |
| Drug Evaluation | 1 | 1977 | 100 | 0.01 | Why? |
| Interleukin-4 | 1 | 1999 | 367 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Interleukin-2 | 1 | 1999 | 443 | 0.01 | Why? |
| Cytokines | 1 | 1999 | 15010 | 0.01 | Why? |
| Fetal Blood | 1 | 1999 | 573 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Academic Medical Centers | 1 | 2006 | 3088 | 0.01 | Why? |
| Immunophenotyping | 1 | 1999 | 1290 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Interleukin-10 | 1 | 1999 | 1409 | 0.01 | Why? |
| Lymphocyte Subsets | 1 | 1999 | 987 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Interferon-gamma | 1 | 1999 | 2711 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Cells, Cultured | 1 | 1999 | 5835 | 0.01 | Why? |
| Lymphocyte Count | 1 | 1999 | 4758 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.00 | Why? |
| Young Adult | 1 | 2014 | 93724 | 0.00 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
| Middle Aged | 1 | 2018 | 270681 | 0.00 | Why? |
| Adult | 1 | 2014 | 244371 | 0.00 | Why? |
| Cross-Sectional Studies | 1 | 1999 | 53120 | 0.00 | Why? |